Logan is focused on developing AAV production strategies for virally mediated delivery of Life Edit’s novel RNA guided nucleases. He has been working with viral vectors for over 8 years.
Prior to Life Edit, Logan spent two and a half years managing the Duke Viral Vector Core where he specialized in AAV and lentivirus applications for neurodegenerative diseases.
Logan received his PhD in Neuroscience from UNC Chapel Hill.
.svg)
.svg)
To rewrite the future by curing disease, making any edit, anywhere.
To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.
We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.
